Pipeline Moves: Phase I/II cystic fibrosis trial of Horizon asset cancelled, shot at further study drops
Novartis in uveal melanoma and Ascendis in hypoparathyroidism are also reviewed by Clinical Trials Arena.
By
Novartis in uveal melanoma and Ascendis in hypoparathyroidism are also reviewed by Clinical Trials Arena.
ByOPKO Health and Pfizer have reported positive results from the Phase III clinical trial of somatrogon compared to Genotropin (somatropin)…